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Abstract
Aims Survival rates after in-hospital cardiac arrest remain very low. Although there is evidence that the use of audiovisual
feedback devices can improve compression components, there are no data on patient survival. Therefore, we conducted this
study to analyse the survival rate of patients with in-hospital cardiac arrest after discharge from the intensive care unit.
Methods and results This study was a secondary analysis of a prospective, randomized, controlled, parallel study of patients
who received either standard manual chest compression or a real-time feedback device. Parametric and semi-parametric
models were fitted to the data. Different survival time of length of stay was investigated by univariate and multiple analyses.
Pearson’s correlation between length of stay and hospital length of stay was obtained. A total of 900 patients with a mean
survival time of 35 days were included. Intervention was associated with a higher length of stay. Relative time was significant
in adjusted fitted log-normal regression for intervention group, female gender, and cardiopulmonary resuscitation in the night
shift. A positive correlation between length of stay and hospital length of stay was found.
Conclusions Implementation of feedback device improved survival and length of stay. Cardiopulmonary resuscitation
performance during the night shift decreased the survival time, which could be due to the inexperienced staff available
outside working hours.
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Introduction
In-hospital cardiac arrest (IHCA) is associated with consider-
able morbidity and mortality. Cardiac arrest survival rate is still
low despite cardiopulmonary resuscitation (CPR). During CPR,
chest compression quality is the key for patient survival.1,2
Various devices have been developed to improve the consis-
tency and quality of chest compressions.3–6 Some of these
devices are combined with feedback technology to help guide
or inform rescuers of CPR. The complexity of CPR audiovisual
feedback (AVF) devices ranges from a simple metronome to
more complex metronome, which produces regular audible
rhythms to help rescuers keep up. They measure CPR perfor-
mance in real time and provide audiovisual information to
guide rescuers to reach target depth and rate.7,8 Several
clinical and simulation studies have reported improved quality
of compression components using AVF devices.9–15
Furthermore, both the American Heart Association and the
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International Liaison Committee on Resuscitation have issued
cautious recommendations to support the use of AVF
equipment.16–18
The AVF devices can be categorized as devices related or
unrelated to automated external defibrillators (AEDs).19,20
The non-AED devices are small, lightweight, portable devices
that are positioned between the patient and rescuer. One of
the devices in this category is Cardio First Angel™ (CFA;
INOTECH, Nubberg, Germany), non-AED and an active com-
pression–passive decompression feedback system, which
was designed for use by both laypersons and healthcare
professionals.21 CFA is positioned on the patient’s chest where
the rescuer’s hands would normally be positioned during
manual CPR, and compressions are performed on the device.
The use of feedback devices to optimize CPR quality has
been suggested in many previous studies, but it has not been
shown to be associated with overall survival, so far.22–25 De-
termining which resuscitation practices distinguish hospitals
with high survival rates for IHCA remains a critical next step
to advancing care in these high-risk patients.26 Therefore,
we conducted this trial study to determine whether the use
of CFA compression feedback device improves rates of
survival in intensive care unit (ICU) and hospital discharge
for patients with IHCA.
Methods
Study design and settings
This study was a secondary analysis of a clinical trial. Its pri-
mary aim (i.e. sustained return of spontaneous circulation)
has been achieved.21 We sought to test a secondary objective
(i.e. survival to ICU and hospital discharge) in the current
study. The prospective, randomized, controlled, parallel study
was conducted in Iran from 1 January 2015 to 15 September
2015. Study patients underwent resuscitation for the IHCA in
medically and surgically mixed ICUs from eight academic
higher care hospitals. All sections of the study illustrated in
Figure 1 are according to the Consolidated Standards of
Reporting Trials statement.27 The trial was registered at
clinicaltrials.gov (Identifier NCT02845011). In the protocol,
crossover design was not allowed.
Figure 1 Flow chart of patient enrolment. CFA, Cardio First Angel™; CPR, cardiopulmonary resuscitation; ICU, intensive care unit.
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Randomization and blinding
Block randomization was performed in four-person groups
using a random number list generated by random allocation
software © (Informer Technologies, Inc., Madrid, Spain;
Figure 1). The numbers were placed in successive containers
to be kept in a safe place until allocation. The allocation
sequences and participant’s enrolment were performed
separately by different researchers to ensure blindness. The
third researcher was responsible for follow-up and assess-
ment of patients. Emergency department enrolment and
randomization were only selected from patients admitted to
ICU. Hence, patients who agreed to enrol in the study had re-
ceived cardiac arrest treatment during the intensive care unit
stay. A container was located at the foot of the bed, contain-
ing either a CFA (intervention) or a sham (control) device. As
soon as the resuscitation began, the container would be
opened and the providers would perform the resuscitation
accordingly. After the trial, no significant changes were made
in the methods and the study ended after receiving the
required sample size. In addition, patients and data analyser
were blinded to randomization. However, healthcare
providers were not blind at the time of resuscitation because
it was considered unethical to use a sham device.
Inclusion and exclusion criteria
Inclusion criteria in this study, in addition to admission to the
ICU of emergency department, were as follows: (i) age over
18 years, (ii) patients with cardiac arrest, (iii) resuscitation
status (full code), and (iv) informed consent. The latter was
obtained, at admission, by the patient’s legal guardian or
healthcare proxy if the patient did not have decision-making
capacity. Exclusion criteria were as follows: (i) cardiac arrest
prior to enrolment at the emergency department or cardiac
arrest out of hospital, (ii) code status except for full code,
(iii) cancelled consent, and (iv) missing or incomplete data
due to any logical obstacles during data collection and
pregnancy.
Participants and procedure
A total of 1396 patients (or legal guardian or an appropriate
successor who was able to make consent decisions) signed
consent at randomization. Decisions to cease resuscitation
efforts were made by the team leader in accordance with
the European Resuscitation Council and American Heart
Association guidelines. These decisions comprised (i) asystole
for more than 20 min in the absence of any reversible
cause [e.g. cardiac tamponade, tension pneumothorax,
distributive shock (anaphylaxis), hypothermia at the time of
arrest, and chemical intoxication/overdose (e.g. opiate)], (ii)
resuscitation longer than 30 min without ventricular
fibrillation or ventricular tachycardia any time (initial or
subsequent rhythm), (iii) injury incompatible with life, and
(iv) co-morbidities’ severity.18,28 The decision for ceasing
resuscitation was made for those patients with ventricular
fibrillation or ventricular tachycardia without continuous
pulse and unresponsive to CPR, defibrillation, and
medications. These decisions were also made on the basis
of clinical parameters such as evident vs. non-evident arrest,
time to start CPR, co-morbidities, and pre-arrest state.
Intervention
All arrests that occurred in ICU were categorized as evidenced
and simultaneously monitored. One intensivist, three to five
ICU nurses, and a respiratory specialist consisted the resusci-
tation team. The resuscitation was performed based on stan-
dard guidelines as follows: (i) chest compression carried out
by skilled ICU nurses, (ii) defibrillation (either conventional
method or automated), (iii) prescribed medications (e.g. epi-
nephrine, vasopressin, atropine, amiodarone, sodium bicar-
bonate, calcium chloride, and magnesium sulfate), and (iv)
ventilation in the presence or absence of endotracheal
intubation. The defibrillation technique was the same as the
standard baseline procedure for all participants. All ICU
nurses received standard CPR training in accordance with
published guidelines and were trained to use CFA device at
approved study centres.29,30 Patients in the control group re-
ceived CPR according to the published guidelines. Conversely,
the CFA feedback device was applied for chest compressions
in intervention group. Invasive haemodynamic measure-
ments were beyond the scope of this study.
Cardio First Angel device
Cardio First Angel is a lightweight three-component handheld
device. The rescuer side has a red palm-sized press button
along with a pictogram to display the proper usage of the de-
vice (Figure 2). The patient side has a liquid absorbable poly-
urethane foam. The central unit consists of a spring-loaded
plastic base. Once the pressure force reaches 400 ± 30 N,
an audible ‘click’ notifies the rescuer to stop the compres-
sion. Similarly, releasing the compression is followed by
another click that indicates compression resumption.7
Data collection
The secondary outcomes of the trial were survival to ICU and
hospital discharge. Survival time was defined as the ICU
length of stay (days), and ICU survival was defined as a binary
variable (alive and dead) to indicate the survival status of the
patient. Collected demographic data included treatment
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received, sex, age, intubation prior to CPR initiation, intuba-
tion during CPR, multi-organ dysfunction (respiratory,
haematology, liver, cardiovascular, central nervous system,
and renal), CPR shift, CPR duration, initial rhythm, first shock,
biphasic shock, diagnosis, underlying osteoporosis, and fre-
quency of conducted CPR. There were no important changes
to methods after trial commencement. Information for inva-
sive arterial monitoring and capnography wave was not re-
ported as these procedures are not commonly available for
patients.
Statistical analyses and modelling
Final sample size assuming an alpha of 0.05, a power of 0.9,
and 10% attrition, based on survival and morbidity data,
was 450 subjects per group. Calculations were performed
using STATA® 14 (StataCorp LLC, College Station, TX, USA).
Variables were individually entered into the crude Cox model,
and the significant ones were entered into the multiple Cox
proportional hazard model. Proportional hazard assumption
was evaluated by Schoenfeld residuals. Parametric models in-
cluding Weibull, log-normal, and log-logistic were fitted to
the data; the Weibull model could be expressed by both haz-
ard ratio and relative survival time, while the log-logistic and
log-normal model could only be expressed by relative survival
time, that is, time ratio (TR). The fitted models were subse-
quently compared using Akaike information criterion (AIC)
in which a lower AIC indicates a better fit. Besides, the frailty
component with gamma distribution was added to the
best-fitted model to account for variability unaccounted by
the model. Finally, the correlation between ICU length of stay
and hospital length of stay was estimated using Spearman’s
rho correlation coefficient.
Results
Participants of the study
Of the 1454 subjects assessed for eligibility, 58
pre-randomization and 496 post-randomization (control and
intervention groups) were excluded (554 subjects were ex-
cluded overall). Thus, data were analysed in 900 patients dur-
ing ICU stay (Figure 1). The high number of ICU patients was
because most of them had internal diseases or serious sur-
gery and so were transferred to the general ICU (about half
of the patients had multi-organ dysfunction syndrome, which
had significantly lower sustained return of spontaneous circu-
lation). The mean and median of staying in ICU were 34.70
(SE = 0.82) and 30 (SE = 0.62) days, respectively. Descriptive
statistic of study participants is shown in Table 1.
Findings of crude Cox model
The crude models of Cox and log-normal were fitted (Table 2).
In the crude Cox model, the intervention group had nearly
50% lower hazard compared with the control group [hazard
ratio = 0.51 (0.42, 0.61), P < 001]. Women had 32% worsen
survival time compared with men [hazard ratio = 1.32 (1.10,
1.59), P< 001]. However, the results of the log-normal model
show that the patients who received intervention had 32%
better survival time compared with the ones who received
control [TR = 1.32 (1.23, 1.42), P < 001] and women had
13% lower survival time compared with men [TR = 0.87
(0.80, 0.92), P < 001]. The time of the day in which the
CPR was performed was also significant in the crude
log-normal model. Patients who underwent CPR during night
shift had 14% worse survival time compared with the ones
who received CPR during the morning shift [TR = 0.86 (0.76,
0.98), P = 0.02]. The duration of CPR longer than 43 min re-
duced the survival time by 10% [TR = 0.90 (0.84, 0.97),
P < 0.01]. These significant factors were entered into the
multiple Cox and log-normal model. The result of multiple
Cox regression indicated a significant value for intervention
(P-value <0.01) and sex (P-value<0.01); however, the pro-
portional hazard assumption was not satisfied for these two
variables.
Figure 2 Pictogram for displaying the proper use of the device.
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Different parametric models
Different parametric models such as Cox,Weibull, log-logistic,
log-normal, and log-normal with gamma frailty were com-
pared using AIC. Among these models, log-normal distribu-
tion with gamma frailty and the lowest AIC showed the
best fit. The results of the AIC comparison are shown in
Supporting Information, Table S3. After fitting the
log-normal model with gamma frailty, significant variables in
the crude model including treatment, sex, CPR shift, and
CPR duration were entered into the multiple models.
Findings of multiple regression model
As illustrated in Supporting Information, Table S4, patients
who received the intervention had 31% better survival time
compared with the control group [TR = 1.31 (1.22, 1.40),
P < 001] (Supporting Information, Figure S3). Women
compared with men had a 13% worse survival time
[TR = 0.87 (0.81, 0.93), P < 0.01] (Supporting Information,
Figure S4). In addition, CPR performed during night shift re-
duced the survival time by 15% [TR = 0.85 (0.75, 0.97),
P = 0.01] (Supporting Information, Figure S5).
Correlation between hospital and intensive care
unit length of stay
The descriptive statistics of the ICU length of stay and hos-
pital length of stay are shown in Supporting Information,
Table S5. The mean and median staying in hospital were
52.75 and 46 days, respectively. There was also a high pos-
itive correlation between these two variables (P < 0.001).
The results of survival analysis on length of stay for ICU
and hospital were similar, so we only showed the ICU anal-
ysis in this study.
Table 1 Summary of survival time of ICU length of stay (days)
Variable Number of patients Number of mortality Mean survival time (SE)
Treatment Intervention 450 181 39.57 (1.37)
Control 450 299 30.34 (0.94)
Sex Female 546 293 33.61 (1.14)
Male 354 187 36.58 (1.16)
Intubated prior to CPR event Yes 368 195 35.16 (1.28)
No 532 285 34.47 (1.06)
Intubated during CPR Yes 70 39 32.45 (2.06)
No 830 441 34.92 (0.87)
Multi-organ dysfunction Yes 438 245 34.64 (1.17)
No 462 235 34.24 (1.08)
CPR shift Night 103 56 32.59 (2.86)
Evening 310 172 33.80 (1.35)
Noon 315 161 36.15 (1.47)
Morning 172 91 35.50 (1.72)
Rhythm Asystole 368 205 34.63 (1.33)
VT 71 32 34.32 (3.29)
VF 103 63 31.25 (1.46)
Bradycardia 358 180 35.40 (1.28)
First shock Yes 106 61 31.68 (1.83)
No 794 419 35.12 (0.90)
Biphasic shock 0 484 266 34.46 (1.02)
400 120 52 35.71 (2.12)
600 155 85 35.39 (2.11)
800 109 59 30.76 (2.47)
1000 32 18 36.63 (3.69)
Age ≤55 456 238 34.04 (1.05)
>55 444 242 35.04 (1.19)
CPR duration ≤43 450 239 35.87 (1.22)
>43 450 241 33.04 (0.98)
Frequency of conducted CPR 1 422 238 34.50 (1.06)
2 433 217 35.67 (1.42)
3 45 25 30.35 (1.87)
Diagnosis Trauma 41 21 35.47 (4.49)
Neurological 169 84 37.51 (2.13)
Renal 219 124 34.69 (1.7)
Cancer 228 128 31.55 (1.05)
Respiratory 198 93 33.04 (1.05)
Abdominal infection 45 30 32.03 (2.48)
Osteoporosis Yes 438 219 35.98 (1.33)
No 462 261 33.49 (0.96)
CPR, cardiopulmonary resuscitation; ICU, intensive care unit; SE, standard error; VF, ventricular fibrillation; VT, ventricular tachycardia.
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Discussion
Improved survival after cardiac arrest occurs regardless of
whether or not the initial cardiac arrest rhythm is responsive
to defibrillation. This implies the potential role of other fac-
tors in improvement of survival such as early recognition of
cardiac arrest, quality of acute resuscitation, use of feedback
devices to optimize CPR quality, and post-resuscitation care.
Mean survival time of ICU length of stay in the study was
34.70 days, which is consistent with the study by Lipsett
et al.31 However, it is considerably higher than the mean
ICU length of stay in several studies.32–36 The differences in
survival time among studies might be related to several fac-
tors such as differences in definition of survival, populations,
or the study settings.37
In the current study, relative time was significant in ad-
justed fitted log-normal regression for intervention, female
gender, and CPR in night shift. According to the results, sur-
vival time in the intervention group was 31% better than
the control group, female patients had 13% shorter survival
time than men, and CPR performed during the night shift
reduced survival time by 15%. Based on a retrospective study
conducted by Böhmer et al.,36 conservative treatment was
significantly associated with improvement in ICU length of
stay. Inconsistent with our results, the results of Böhmer
et al.36 study showed that women had a better survival rate.
In addition, previous studies have shown that CPR carried out
during the day yielded more favourable outcome, which was
consistent with our results.38–40 However, in the studies by
Goharani et al.41 and Vahedian-Azimi et al.,21 CPR perfor-
mance did not have any significant association with the
survival.
In line with our results, a study by Syue et al.42 reported
that the chance of survival of patients with IHCA was lower
during the night shift than the morning or evening shift.
However, Goharani et al.41 study employed multiple logistic
regression and did not find any significant association
between the CPR performance on any time of the day and
survival. It should be noted that CPR delivered during
working hours (8 a.m. to 4 p.m.) usually results in more sur-
vivors than those performed outside working hours (4 p.m.
to 8 a.m.). Although the ICU has highly skilled staff and fully
Table 2 Results of crude regressions of ICU length of stay (days)
Variable
Crude Cox model Crude log-normal model
Hazard ratio (95% CI) P-value Relative time (95% CI) P-value
Treatment Intervention 0.51 (0.42, 0.61) <0.01* 1.32 (1.23, 1.42) <0.01*
Control Ref Ref
Sex Female 1.32 (1.10, 1.59) <0.01* 0.87 (0.80, 0.92) <0.01*
Male Ref Ref
Intubated prior to CPR event Yes 0.98 (0.82, 1.18) 1.02 (0.95, 1.09) 0.64
No Ref Ref
Intubated during CPR Yes 1.06 (0.77, 1.48) 0.69 0.99 (0.87, 1.13) 0.88
No Ref Ref
Multi-organ dysfunction Yes 1.06 (0.89, 1.28) 0.46 0.97 (0.90, 1.04) 0.41
No Ref Ref
CPR shift Night 1.34 (0.96, 1.88) 0.08 0.86 (0.76, 0.98) 0.02*
Evening 1.15 (0.89, 1.48) 0.28 0.94 (0.85, 1.04) 0.25
Noon 0.98 (0.76, 1.27) 0.88 0.99 (0.89, 1.09) 0.87
Morning Ref Ref
Rhythm Asystole 1.15 (0.94, 1.41) 0.17 0.93 (0.86, 1.01) 0.08
VT 1.06 (0.72, 1.55) 0.77 1.01 (0.88, 1.15) 0.95
VF 1.23 (0.92, 1.64) 0.16 0.91 (0.81, 1.02) 0.09
Bradycardia Ref Ref
First shock Yes 1.23 (0.94, 1.61) 0.14 0.96 (0.86, 1.06) 0.41
No Ref Ref
Age ≤55 Ref Ref
>55 0.98 (0.82, 1.18) 0.85 0.99 (0.92, 1.06) 0.81
CPR duration ≤43 Ref Ref
>43 1.13 (0.94, 1.35) 0.20 0.90 (0.84, 0.97) <0.01*
Frequency of conducted CPR 1 Ref Ref
2 0.99 (082, 1.19) 0.91 0.98 (0.91, 1.05) 0.58
3 1.10 (0.73, 1.66) 0.65 0.96 (0.82, 1.13) 0.61
Diagnosis Trauma Ref Ref
Neurological 0.84 (0.52, 1.36) 0.48 1.05 (0.87, 1.26) 0.61
Renal 1.05 (0.66, 1.67) 0.84 0.95 (0.80, 1.14) 0.61
Cancer 1.10 (0.69, 1.75) 0.68 1.01 (0.85, 1.22) 0.87
Respiratory 0.89 (0.55, 1.44) 0.65 1.08 (0.89, 1.29) 0.46
Abdominal infection 1.16 (0.66, 2.03) 0.60 0.99 (0.79, 1.24) 0.94
Osteoporosis Yes Ref Ref
No 1.12 (0.93, 1.34) 0.23 0.99 (0.79, 1.24) 0.94
CI, confidence interval; CPR, cardiopulmonary resuscitation; ICU, intensive care unit; VF, ventricular fibrillation; VT, ventricular tachycardia.
*Significant at 0.05 level.
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equipped at all times, less experienced and less staff are
available outside working hours. Moreover, tiredness of the
remaining staff can contribute to poor outcome.43
The issue was that there was uncertainty about improving
survival using the feedback devices. By the primary outcome
of return of spontaneous circulation in the Goharani et al.41
study and its secondary analysis of survival to ICU discharge
(which was expanded in this study), we showed the desired
quality of non-AED free-standing AVF devices if it complied
with the revised guidelines. Also, in the meta-analysis study
of Miller et al.,22 the improvement of survival to ICU discharge
was concluded by the AVF devices. It is worth noting that
among the numerous feedback devices, there were fewer
published human randomized controlled trials.21,41,44 Because
of lack of sufficient data, our study will be the basis for the
future.
Limitations
The limitations of this study are as follows: (i) no record of pri-
mary cardiac conditions; (ii) not designed to follow neurolog-
ical outcomes; (iii) not designed to record data on
compression rate and depth, chest recoil, duration of inter-
ruptions, no flow time, or flow fraction; (iv) no report of inva-
sive arterial surveillance and wave form capnography due to
unavailable data; and (v) no report of post-resuscitation pro-
cess. Inability to blind the clinical providers was a notable lim-
itation of compression feedback device studies. It is possible
to blind the subject, the investigator, and the data analyser,
which was performed in this study. However, blinding the
health provider required either (i) use of a sham device or
(ii) hiding the device during compression pauses. Hence,
applying a sham device was deemed to be unethical and
hiding the device was impossible in practice. Besides,
do-not-attempt-resuscitation law does not apply in the coun-
try where the study was conducted. However, only full-code
patients were included in this study. Complex changes in com-
pliance of chest wall as well as compressibility of the surface
the patient is lying on (e.g. mattress) were stated as criticisms
of the current non-AED compression feedback devices. Also,
the non-uniformity of assessment for chest wall complica-
tions, which was partly due to limited funding, prevents the
conclusions from expanding.
Conclusion
Globally, the high rate of cardiac arrest mortalities over these
years may have been due to poor-quality CPR performance
by medical professionals and lay providers. However, our
analysis has demonstrated that the use of CFA non-AED de-
vice provides longer relative survival time among patients.
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